Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning
- 5 November 2021
- journal article
- research article
- Published by Springer Nature in Cognitive Neurodynamics
- Vol. 17 (3) , 803-811
Abstract
The novel coronavirus disease, COVID-19, has rapidly spread worldwide. Developing methods to identify the therapeutic activity of drugs based on phenotypic data can improve the efficiency of drug development. Here, a state-of-the-art machine-learning method was used to identify drug mechanism of actions (MoAs) based on the cell image features of 1105 drugs in the LINCS database. As the multi-dimensional features of cell images are affected by non-experimental factors, the characteristics of similar drugs vary considerably, and it is difficult to effectively identify the MoA of drugs as there is substantial noise. By applying the supervised information theoretic metric-learning (ITML) algorithm, a linear transformation made drugs with the same MoA aggregate. By clustering drugs to communities and performing enrichment analysis, we found that transferred image features were more conducive to the recognition of drug MoAs. Image features analysis showed that different features play important roles in identifying different drug functions. Drugs that significantly affect cell survival or proliferation, such as cyclin-dependent kinase inhibitors, were more likely to be enriched in communities, whereas other drugs might be decentralized. Chloroquine and clomiphene, which block the entry of virus, were clustered into the same community, indicating that similar MoA could be reflected by the cell image. Overall, the findings of the present study laid the foundation for the discovery of MoAs of new drugs, based on image data. In addition, it provided a new method of drug repurposing for COVID-19.Keywords
Funding Information
- National Natural Science Foundation of China (81803431)
This publication has 19 references indexed in Scilit:
- Systematic exploration of cell morphological phenotypes associated with a transcriptomic queryNucleic Acids Research, 2018
- A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 ProfilesCell, 2017
- The Drug Repurposing Hub: a next-generation drug library and information resourceNature Medicine, 2017
- Alternative analgesics: New drugs for pain seek to improve on ketamine's benefitsNature Medicine, 2017
- Clomiphene and Its Isomers Block Ebola Virus Particle Entry and Infection with Similar Potency: Potential Therapeutic ImplicationsViruses, 2016
- Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic DataMolecular Pharmaceutics, 2016
- Antiviral Potential of ERK/MAPK and PI3K/AKT/mTOR Signaling Modulation for Middle East Respiratory Syndrome Coronavirus Infection as Identified by Temporal Kinome AnalysisAntimicrobial Agents and Chemotherapy, 2015
- CellProfiler: image analysis software for identifying and quantifying cell phenotypesGenome Biology, 2006
- Chloroquine is a potent inhibitor of SARS coronavirus infection and spreadVirology Journal, 2005
- Effects of chloroquine on viral infections: an old drug against today's diseasesThe Lancet Infectious Diseases, 2003